While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: SVTACNT-V
$500.00
Lentiviral construct with Dox-responsive GFP/RFP Reporter. A control to test Dox-inducible cell lines for the Tet-Off system.